Ivoryon Therapeutics

BiotechnologySeries BHalle, Germanyvivoryon.com

Latest round

Series B

Last raised

Jan 2012

Total raised

$86M

Investors

10

About Ivoryon Therapeutics

Based in Halle, Germany, and founded in 1997, Ivoryon Therapeutics AG, formerly Probiodrug AG operates as a biopharmaceutical company that specializes in the development of innovative small-molecule drugs. Probiodrug leverages its expertise with novel targets, such as Glutaminyl Cyclase (QC) and Cyclin-Dependent Kinase 9 (CDK9), to develop drugs for the treatment of widespread diseases such as Alzheimer’s disease and chronic inflammation.25 per share.

Who invested in Ivoryon Therapeutics

10 investors across 3 rounds

See all investors in Ivoryon Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jan 4, 2012

    Amount

    $19M

    Investors

    Locked

  2. Series B

    Nov 2, 2009

    Amount

    $54M

    Investors

    Locked

  3. Series C

    Jun 15, 2006

    Amount

    $13M

    Investors

    Locked

Questions about Ivoryon Therapeutics

Who invested in Ivoryon Therapeutics?

Ivoryon Therapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Ivoryon Therapeutics raised?

Ivoryon Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Ivoryon Therapeutics last raise money?

Ivoryon Therapeutics's most recent round on record is a Series B, in Jan 2012.

What does Ivoryon Therapeutics do?

Based in Halle, Germany, and founded in 1997, Ivoryon Therapeutics AG, formerly Probiodrug AG operates as a biopharmaceutical company that specializes in the development of innovative small-molecule drugs.

Where is Ivoryon Therapeutics headquartered?

Ivoryon Therapeutics is headquartered in Halle, Germany.

Which VCs invest in companies like Ivoryon Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Ivoryon Therapeutics's stage. Their profiles are linked below.

Raising like Ivoryon Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.